UA93922C2 - Способ получения пептидов, которые специфически распознают клетки определенного типа, и предназначены для терапевтических целей - Google Patents
Способ получения пептидов, которые специфически распознают клетки определенного типа, и предназначены для терапевтических целейInfo
- Publication number
- UA93922C2 UA93922C2 UAA200902499A UAA200902499A UA93922C2 UA 93922 C2 UA93922 C2 UA 93922C2 UA A200902499 A UAA200902499 A UA A200902499A UA A200902499 A UAA200902499 A UA A200902499A UA 93922 C2 UA93922 C2 UA 93922C2
- Authority
- UA
- Ukraine
- Prior art keywords
- cells
- peptides
- particular type
- production
- therapy
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 11
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 11
- 238000000034 method Methods 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 11
- 238000002560 therapeutic procedure Methods 0.000 abstract 4
- 238000012790 confirmation Methods 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 208000037273 Pathologic Processes Diseases 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000013467 fragmentation Methods 0.000 abstract 1
- 238000006062 fragmentation reaction Methods 0.000 abstract 1
- 238000010353 genetic engineering Methods 0.000 abstract 1
- 230000009054 pathological process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 241001515965 unidentified phage Species 0.000 abstract 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA200902499A UA93922C2 (ru) | 2009-03-20 | 2009-03-20 | Способ получения пептидов, которые специфически распознают клетки определенного типа, и предназначены для терапевтических целей |
| RU2011140269/10A RU2528739C2 (ru) | 2009-03-20 | 2009-03-27 | Способ получения пептидов, специфично распознающих определенные типы клеток и предназначенных для терапевтических целей |
| PCT/UA2009/000011 WO2010107405A1 (ru) | 2009-03-20 | 2009-03-27 | Способ получения пептидов, специфично распознающих определённые типы клеток и предназначенных для терапевтических целей |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA200902499A UA93922C2 (ru) | 2009-03-20 | 2009-03-20 | Способ получения пептидов, которые специфически распознают клетки определенного типа, и предназначены для терапевтических целей |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA93922C2 true UA93922C2 (ru) | 2011-03-25 |
Family
ID=42739879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200902499A UA93922C2 (ru) | 2009-03-20 | 2009-03-20 | Способ получения пептидов, которые специфически распознают клетки определенного типа, и предназначены для терапевтических целей |
Country Status (3)
| Country | Link |
|---|---|
| RU (1) | RU2528739C2 (ru) |
| UA (1) | UA93922C2 (ru) |
| WO (1) | WO2010107405A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2572710C1 (ru) * | 2014-08-13 | 2016-01-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Мордовский государственный университет им. Н.П. Огарёва" | Соединение нибентана с аминокислотой, обладающее противоаритмической активностью, и способ его получения |
| US10724034B2 (en) * | 2014-10-22 | 2020-07-28 | The Governors Of The University Of Alberta | Genetic encoding of chemical post-translational modification for phage-displayed libraries |
| SG11202100721SA (en) | 2018-07-23 | 2021-02-25 | Univ Alberta | Genetically-encoded bicyclic peptide libraries |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| AU2003208520B2 (en) * | 2002-01-22 | 2008-06-05 | Takara Bio Usa, Inc. | Fluorescent protein from aequorea coerulscens and uses therof |
| RU2263146C2 (ru) * | 2003-07-10 | 2005-10-27 | Михаил Викторович Разуменко | Способ получения бактериофагов, специфично связывающихся с клетками-мишенями и предназначенных для терапевтических целей |
| UA66110A (en) * | 2003-07-28 | 2004-04-15 | Mykhailo Viktorovych Razumenko | A method for the preparation of specific peptides for therapeutic purposes |
-
2009
- 2009-03-20 UA UAA200902499A patent/UA93922C2/ru unknown
- 2009-03-27 RU RU2011140269/10A patent/RU2528739C2/ru not_active IP Right Cessation
- 2009-03-27 WO PCT/UA2009/000011 patent/WO2010107405A1/ru not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| RU2011140269A (ru) | 2013-04-27 |
| RU2528739C2 (ru) | 2014-09-20 |
| WO2010107405A1 (ru) | 2010-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | RNA-based diagnostic markers discovery and therapeutic targets development in cancer | |
| Zhao et al. | RNA delivery biomaterials for the treatment of genetic and rare diseases | |
| Kim et al. | Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs | |
| SA522433360B1 (ar) | L-أَسْباراجيناز مُعدل | |
| UA101155C2 (ru) | Модифицированный полипептид фактора vii (fvii) и его применение | |
| MX2009012650A (es) | Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos. | |
| WO2017011773A3 (en) | Codon-optimized nucleic acids encoding antibodies | |
| MX342933B (es) | Acido nucleico que comprende o codifica para una secuencia de tallo-asa de histona y poli (a) o una señal de poliadenilacion para incrementar la expresion de una proteina codificada. | |
| TN2012000372A1 (en) | Fibronectin based scaffold domain proteins that bind il-23 | |
| WO2008020596A3 (en) | Treating or preventing cancers over-expressing reg4 or kiaa0101 | |
| JP2015522264A5 (ru) | ||
| NZ594480A (en) | Methods and compositions for diagnosis and treatment of cancer | |
| WO2004014222A3 (en) | Diagnosis and treatment of tuberous sclerosis | |
| Tsiamantas et al. | Ribosomal incorporation of aromatic oligoamides as peptide sidechain appendages | |
| UA93922C2 (ru) | Способ получения пептидов, которые специфически распознают клетки определенного типа, и предназначены для терапевтических целей | |
| RU2013126581A (ru) | Мутанты стрептокиназы и их ковалентно модифицированные формы | |
| Alammari et al. | Hidden regulators: the emerging roles of lncRNAs in brain development and disease | |
| WO2010018950A3 (en) | Protein scaffold library based on kringle domain structure and uses thereof | |
| WO2020127532A3 (en) | Rna encoding a protein | |
| SA521421036B1 (ar) | ديندريمر علاجي | |
| EP4249598A3 (en) | Hybrid promoters and their uses in therapy, notably for treating type ii collagenopathies | |
| WO2008049643A3 (en) | Gd2 peptide mimotopes for anticancer vaccination | |
| K Tannenberg et al. | Nucleic acid aptamers as novel class of therapeutics to mitigate Alzheimer's disease pathology | |
| EP4282490A3 (en) | Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy | |
| MX2024003615A (es) | Anticuerpos que se unen al cumulo de diferenciacion 30 (cd30) y al cumulo de diferenciacion 3 (cd3). |